Today: 6 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Nebius Group N.V. (NBIS) Stock: Latest News, Analyst Targets, and 2026 Outlook as AI Infrastructure Demand Collides With Heavy Capex (Dec. 15, 2025)

Nebius Group N.V. (NBIS) Stock: Latest News, Analyst Targets, and 2026 Outlook as AI Infrastructure Demand Collides With Heavy Capex (Dec. 15, 2025)

Nebius Group N.V. shares closed at $87.69 on Dec. 12 after a 6.99% drop, following heavy trading and sharp swings in recent sessions. The selloff comes despite major contracts with Microsoft and Meta and rapid revenue growth, as investors weigh high spending and financing risks. Pre-market trading on Dec. 15 showed a slight rebound. Nebius, formerly Yandex N.V., is Europe’s largest neocloud firm, specializing in GPU-heavy AI infrastructure.
15 December 2025
·
Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma shares fell about 8% to $0.095 on December 15, 2025, as the company’s stock transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market. Aspire faces Nasdaq deadlines to regain compliance with minimum bid price and equity rules by early 2026. The company is also advancing an FDA regulatory milestone for its sublingual aspirin program.
15 December 2025
·
Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor shares fell nearly 7% to $6.56 at Monday’s open, continuing a year of sharp swings. The company is undergoing a major shift under new CEO Kaz Nejatian, with a focus on AI and software. A special dividend of tradable warrants and skepticism from analysts have added to volatility. Market cap stands at about $6.3 billion.
15 December 2025
·
GameStop Stock (GME) Today: Q3 2025 Earnings, Bitcoin Treasury Update, and Analyst Forecasts as of Dec. 15, 2025

GameStop Stock (GME) Today: Q3 2025 Earnings, Bitcoin Treasury Update, and Analyst Forecasts as of Dec. 15, 2025

GameStop reported Q3 net sales of $821 million, missing analyst estimates, but posted net income of $77.1 million, up sharply from last year. Collectibles sales rose nearly 50% year-over-year, now making up 31% of revenue. Gross margin improved to 33.3%. The company ended the quarter with $8.8 billion in liquidity and $4.16 billion in long-term debt.
15 December 2025
··
Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp agreed to sell its Brazil operations to a CMOC Group subsidiary for $1.015 billion, including $900 million upfront and up to $115 million contingent on production. Shares traded near $14.70 on Monday after the news. The deal is expected to close in Q1 2026, pending regulatory approvals in Brazil and China. Equinox plans to focus on North American assets.
15 December 2025
···
ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow is in advanced talks to acquire cybersecurity firm Armis for up to $7 billion, according to Reuters. Shares traded near $865 early Dec. 15, down modestly and about 28% below the 52-week high. A 5-for-1 stock split is set for later this week. ServiceNow recently announced plans to buy identity security company Veza, pending regulatory approval.
15 December 2025
·
Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital shares closed at $27.86 on December 15, down 9.4% in one session after a strong multi-month rally. The company, now valued near $7–8 billion, has shifted focus from crypto to AI data centers, highlighted by two 15-year CoreWeave leases worth $7 billion. Investors cite volatility and risks tied to capital needs and tenant concentration.
15 December 2025
·
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.
15 December 2025
·
Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi shares fell about 4% in Paris on December 15 after the company reported a U.S. regulatory delay for tolebrutinib in non-relapsing secondary progressive MS and a failed Phase 3 trial in primary progressive MS. Sanofi will not seek approval for the latter indication. The FDA decision for nrSPMS is now expected after December 28, with further guidance by end of Q1 2026.
15 December 2025
···
Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba’s U.S.-listed shares traded near $155.68 on Dec. 15, 2025, within a volatile 52-week range of $80.06 to $192.67. The company has committed over $52 billion to AI and cloud infrastructure, raising concerns about rising capital expenditures outpacing revenue. Its Qwen AI app surpassed 10 million downloads in its first week and is now integrated into Quark, reaching over 200 million users in China.
15 December 2025
···
New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy shares traded near $1.26 Monday, down 2.3%, as the company faces a December 15 deadline tied to a forbearance agreement on missed interest payments for its 2029 Notes. The agreement covers holders of over 70% of the notes and could trigger acceleration of debt if not extended or restructured. The stock sits near its 52-week low after a year of heavy volatility. Investors remain focused on debt negotiations.
15 December 2025
·
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group (Nasdaq: WOK) traded around $0.11 on Dec. 15, 2025, after a 1-for-100 reverse split and repeated Nasdaq bid-price warnings. The stock’s 52-week range shows extreme volatility, distorted by the split and thin trading. A Nasdaq volatility halt was triggered on Dec. 10. The company supplies medical devices in China and exports to over 30 countries.
15 December 2025
·
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica shares fell 12.78% to $306.50 on December 12 amid a broader tech selloff linked to concerns over AI valuations and rising borrowing costs. The stock rebounded in early pre-market trading December 15, indicated at $312.10. B. Riley Wealth Advisors disclosed a new stake of 11,319 shares, while director Laurette T. Koellner bought 6,000 shares in October. Institutional investors hold about 67% of Celestica shares.
15 December 2025
·
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping shares fell 5.4% to $18.76 on Dec. 15, 2025, amid takeover speculation and a pending shareholder vote. The board confirmed a strategic review after receiving a non-binding acquisition proposal from CEO Eli Glickman and Rami Ungar. Reports say MSC and Hapag-Lloyd have also submitted bids. Any sale would require shareholder and Israeli government approval.
15 December 2025
···
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

The FDA approved Milestone Pharmaceuticals’ CARDAMYST (etripamil) nasal spray for adults with paroxysmal supraventricular tachycardia, marking the first new U.S. PSVT treatment in over 30 years. The company targets retail availability in Q1 2026. Shares showed sharp volatility after the announcement. Milestone scheduled an investor call for December 15 to discuss launch plans.
15 December 2025
·
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace shares rose about 4% to $299.81, following Citigroup’s initiation of coverage with a Buy rating and $386 target. The company also secured orders to supply LM2500 engines for two U.S. Navy destroyers. Meanwhile, the FAA issued a new airworthiness directive for certain CFM LEAP-1A engines after reports of blade cracks.
15 December 2025
···
Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron shares fell 6.7% to $241.14 ahead of its fiscal Q1 2026 earnings report set for Dec. 17. Options markets are pricing in a post-earnings move of about ±10.8%. Wall Street expects revenue near $12.6–$12.8 billion and EPS around $3.84–$3.91, driven by strong AI-related demand and higher memory prices.
15 December 2025
··
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.
15 December 2025
·
1 … 453 454 455 456 457 … 587

Stock Market Today

  • Aduro Clean Technologies TSX Listing Spurs Valuation Debate Amid Hydrochemolytic Progress
    June 5, 2026, 6:43 PM EDT. Aduro Clean Technologies (TSX:ACT) gained attention following its Toronto Stock Exchange listing and advancements in its Hydrochemolytic Technology projects in Ontario and Europe. The stock showed a 31.7% return over 90 days but dropped nearly 17% in the last week to CA$19.52. Its price-to-book ratio stands at 16.3x, far exceeding the peer average of 1.8x and Canadian Software sector's 3.1x, suggesting the market values future growth over current assets. A discounted cash flow (DCF) model estimates a fair value of CA$14.84, indicating potential overvaluation. Current revenues remain low at CA$0.24 million, and losses are at CA$18.13 million, presenting risks if growth stalls. Investors weigh high expectations against the risk of weak near-term earnings in this emerging clean tech play.

Latest articles

Sandisk’s AI rally stalls as chip wipeout hits $1.3 trillion

Sandisk’s AI rally stalls as chip wipeout hits $1.3 trillion

6 June 2026
Sandisk plunged 11.4% to $1,559.32 after the PHLX Semiconductor Index suffered its worst day since March 2020, wiping $1.3 trillion from U.S. chipmakers as investors questioned AI storage demand durability and supply-cycle risks despite Sandisk’s record data-center revenue and $42 billion in long-term deals.
Micron Drops 13% as Chip Selloff Hits $1.3 Trillion Shakeout

Micron Drops 13% as Chip Selloff Hits $1.3 Trillion Shakeout

6 June 2026
Micron Technology plunged 13% Friday, erasing $150 billion in market value as part of a $1.3 trillion semiconductor selloff, despite record revenue and Nvidia qualifying Micron’s HBM4 chips; investors punished “good but not better” AI news amid rate fears and high expectations, with the next earnings test set for June 24.
VIX Up 40% After AI Stocks Slip, Jobs Report Shakes Wall St

VIX Up 40% After AI Stocks Slip, Jobs Report Shakes Wall St

6 June 2026
Wall Street’s fear gauge soared nearly 40% to 21.51 as a tech-led selloff erased $1.3 trillion from U.S. chipmakers, with the Nasdaq plunging 4.2% and the S&P 500 down 2.6% after strong jobs data fueled fresh rate hike fears and ended a nine-week S&P rally.
NuScale shares rise 5% as investors watch small-nuclear sector test

NuScale Stock Plunges as the Nuclear Boom Trade Hits a Wall

5 June 2026
NuScale Power plunged 12.6% to $10.50 in late trading Friday as Wall Street’s sharp selloff hammered technology-linked and speculative power stocks, with investors reacting to a hawkish Fed outlook and recent analyst caution on NuScale’s near-term prospects despite its NRC-approved reactor design and $1 billion in liquidity.
Go toTop